CCP
Clough Capital Partners Portfolio holdings
AUM
$997M
This Quarter Return
+6.97%
1 Year Return
+37.42%
3 Year Return
+130.83%
5 Year Return
+251.5%
10 Year Return
+1,002%
AUM
$977M
AUM Growth
+$977M
(+6.7%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
3.68%
Top 10 Holdings %
Top 10 Hldgs %
35.78%
Holding
149
New
31
Increased
28
Reduced
46
Closed
17
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$19.5M |
| 2 |
Dell
DELL
|
$17.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$14.9M |
| 4 |
Fidelis Insurance
FIHL
|
$11.4M |
| 5 |
Agilent Technologies
A
|
$10.7M |
Top Sells
| 1 |
Merck
MRK
|
$16M |
| 2 |
Eli Lilly
LLY
|
$15M |
| 3 |
Microsoft
MSFT
|
$14.1M |
| 4 |
UnitedHealth
UNH
|
$11.6M |
| 5 |
Apple
AAPL
|
$10.7M |
Sector Composition
| 1 | Consumer Discretionary | 22.48% |
| 2 | Technology | 20.72% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 12% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Acadia Healthcare
ACHC
$2.15B
| $294K | 0.03% |
4,640
-4,700
| -50% | -$298K |
|
127
Humana
HUM
$37.5B
| $260K | 0.03% |
820
| – | – |
|
128
BioMarin Pharmaceuticals
BMRN
$11.3B
| $252K | 0.03% |
3,580
| – | – |
|
|
ITCI
129
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $249K | 0.03% |
3,400
| – | – |
|
130
Cross Country Healthcare
CCRN
$420M
| $214K | 0.02% |
+15,900
| New | +$214K |
|
131
AMN Healthcare
AMN
$760M
| $203K | 0.02% |
+4,800
| New | +$203K |
|
132
Planet Labs
PL
$1.95B
| $139K | 0.01% |
62,300
-81,038
| -57% | -$181K |
|
|
NARI
133
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-24,234
| Closed | -$1.17M |
|
|
INFN
134
DELISTED
Infinera Corporation Common Stock
INFN
| – | – |
-40,800
| Closed | -$248K |
|
135
Reddit
RDDT
$41.8B
| – | – |
-130,218
| Closed | -$8.32M |
|
136
Starbucks
SBUX
$99.2B
| – | – |
-14,393
| Closed | -$1.12M |
|
137
On Holding
ONON
$14.6B
| – | – |
-12,745
| Closed | -$495K |
|
138
Nike
NKE
$110B
| – | – |
-4,800
| Closed | -$362K |
|
|
139
Merck
MRK
$210B
| – | – |
-129,503
| Closed | -$16M |
|
140
Lam Research
LRCX
$124B
| – | – |
-2,892
| Closed | -$3.08M |
|
141
International Seaways
INSW
$2.27B
| – | – |
-170,850
| Closed | -$10.1M |
|
142
Hologic
HOLX
$14.7B
| – | – |
-7,160
| Closed | -$532K |
|
143
Helix Energy Solutions
HLX
$952M
| – | – |
-102,869
| Closed | -$1.23M |
|
144
Chart Industries
GTLS
$8.94B
| – | – |
-8,666
| Closed | -$1.25M |
|
145
General Mills
GIS
$26.6B
| – | – |
-35,600
| Closed | -$2.25M |
|
146
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
-20,939
| Closed | -$1.13M |
|
147
Arcellx
ACLX
$3.95B
| – | – |
-4,800
| Closed | -$265K |
|
148
Arcos Dorados Holdings
ARCO
$1.44B
| – | – |
-116,481
| Closed | -$1.05M |
|
149
Biogen
BIIB
$20.8B
| – | – |
-42,800
| Closed | -$9.92M |
|